
Jennifer Sue Pitrak Mcdonald
Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1609, 3796, 3792, 1635, 1674 |
| Total Applications | 600 |
| Issued Applications | 220 |
| Pending Applications | 26 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5739019
[patent_doc_number] => 20060009410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Effects of apolipoprotein B inhibition on gene expression profiles in animals'
[patent_app_type] => utility
[patent_app_number] => 11/123656
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41573
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123656
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123656 | Effects of apolipoprotein B inhibition on gene expression profiles in animals | May 4, 2005 | Abandoned |
Array
(
[id] => 7172218
[patent_doc_number] => 20050203049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => '47169 and 33935, novel human glycosyl transferases and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/120749
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 39128
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203049.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120749
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120749 | 47169 and 33935, novel human glycosyl transferases and uses therefor | May 2, 2005 | Abandoned |
Array
(
[id] => 4687674
[patent_doc_number] => 20080031855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Anticancer Agent Containing Minus-Strand Rna Virus'
[patent_app_type] => utility
[patent_app_number] => 11/630522
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15458
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20080031855.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630522 | Anticancer Agent Containing Minus-Strand Rna Virus | Apr 27, 2005 | Abandoned |
Array
(
[id] => 5771612
[patent_doc_number] => 20050267063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Antisense modulation of p70 S6 kinase expression'
[patent_app_type] => utility
[patent_app_number] => 11/117013
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26155
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117013 | Antisense modulation of p70 S6 kinase expression | Apr 26, 2005 | Abandoned |
Array
(
[id] => 7136686
[patent_doc_number] => 20050181442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'HCaRG, a novel calcium-regulated gene coding for a nuclear protein'
[patent_app_type] => utility
[patent_app_number] => 11/108784
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15252
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108784
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108784 | HCaRG, a novel calcium-regulated gene coding for a nuclear protein | Apr 18, 2005 | Abandoned |
Array
(
[id] => 5247831
[patent_doc_number] => 20070244065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Composition Comprising a Survivin Oligonucleotide and Gemcitabine for The Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/587219
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4700
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244065.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587219 | Composition Comprising a Survivin Oligonucleotide and Gemcitabine for The Treatment of Cancer | Apr 14, 2005 | Abandoned |
Array
(
[id] => 7005111
[patent_doc_number] => 20050170424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Gankyrin'
[patent_app_type] => utility
[patent_app_number] => 11/083944
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19130
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20050170424.pdf
[firstpage_image] =>[orig_patent_app_number] => 11083944
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/083944 | Gankyrin | Mar 20, 2005 | Issued |
Array
(
[id] => 5760055
[patent_doc_number] => 20060211000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Methods, compositions, and kits for detection of microRNA'
[patent_app_type] => utility
[patent_app_number] => 11/084082
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 22361
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211000.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084082
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084082 | Methods, compositions, and kits for detection of microRNA | Mar 20, 2005 | Abandoned |
Array
(
[id] => 4555112
[patent_doc_number] => 07820809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Functional and hyperfunctional siRNA directed against Bcl-2'
[patent_app_type] => utility
[patent_app_number] => 11/083784
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 50265
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820809.pdf
[firstpage_image] =>[orig_patent_app_number] => 11083784
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/083784 | Functional and hyperfunctional siRNA directed against Bcl-2 | Mar 17, 2005 | Issued |
Array
(
[id] => 7216458
[patent_doc_number] => 20050260163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Triplex hairpin ribozyme'
[patent_app_type] => utility
[patent_app_number] => 11/081251
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260163.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081251 | Triplex hairpin ribozyme | Mar 15, 2005 | Abandoned |
Array
(
[id] => 7224164
[patent_doc_number] => 20050261225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells'
[patent_app_type] => utility
[patent_app_number] => 11/081140
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6401
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261225.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081140
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081140 | Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells | Mar 14, 2005 | Abandoned |
Array
(
[id] => 4922751
[patent_doc_number] => 20080071068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Cytoplasmic Localization Dna and Rna'
[patent_app_type] => utility
[patent_app_number] => 10/589955
[patent_app_country] => US
[patent_app_date] => 2005-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20080071068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589955
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589955 | Cytoplasmic Localization Dna and Rna | Feb 20, 2005 | Abandoned |
Array
(
[id] => 5638076
[patent_doc_number] => 20060069050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Methods and compositions for mediating gene silencing'
[patent_app_type] => utility
[patent_app_number] => 11/060905
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15342
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069050.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060905
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060905 | Methods and compositions for mediating gene silencing | Feb 16, 2005 | Abandoned |
Array
(
[id] => 7256897
[patent_doc_number] => 20050273868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Methods and compositions for enhancing RISC activity in vitro and in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/060851
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11200
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20050273868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060851
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060851 | Methods and compositions for enhancing RISC activity in vitro and in vivo | Feb 16, 2005 | Abandoned |
Array
(
[id] => 8294607
[patent_doc_number] => 08222393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Polypeptide useful for cancer diagnosis and treatment'
[patent_app_type] => utility
[patent_app_number] => 11/628056
[patent_app_country] => US
[patent_app_date] => 2005-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12339
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11628056
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628056 | Polypeptide useful for cancer diagnosis and treatment | Jan 31, 2005 | Issued |
Array
(
[id] => 6931729
[patent_doc_number] => 20050282764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Method of identifying nucleic acid compositions for muting expression of a gene'
[patent_app_type] => utility
[patent_app_number] => 11/041797
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13151
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041797
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041797 | Method of identifying nucleic acid compositions for muting expression of a gene | Jan 23, 2005 | Abandoned |
Array
(
[id] => 5285385
[patent_doc_number] => 20090099060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Modulation of line-1 reverse transcriptase'
[patent_app_type] => utility
[patent_app_number] => 10/586434
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13776
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586434
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586434 | Modulation of line-1 reverse transcriptase | Jan 17, 2005 | Abandoned |
Array
(
[id] => 6952844
[patent_doc_number] => 20050227939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Modulation of kallikrein 6 expression'
[patent_app_type] => utility
[patent_app_number] => 11/036095
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20492
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227939.pdf
[firstpage_image] =>[orig_patent_app_number] => 11036095
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/036095 | Modulation of kallikrein 6 expression | Jan 13, 2005 | Abandoned |
Array
(
[id] => 6997382
[patent_doc_number] => 20050137160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Antisense modulation of cholesteryl ester transfer protein expression'
[patent_app_type] => utility
[patent_app_number] => 11/031827
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25896
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031827 | Antisense modulation of cholesteryl ester transfer protein expression | Jan 6, 2005 | Abandoned |
Array
(
[id] => 7039346
[patent_doc_number] => 20050158780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Nucleic acid ligands to the prostate specific membrane antigen'
[patent_app_type] => utility
[patent_app_number] => 11/029949
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10970
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158780.pdf
[firstpage_image] =>[orig_patent_app_number] => 11029949
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/029949 | Nucleic acid ligands to the prostate specific membrane antigen | Jan 3, 2005 | Abandoned |